Detalhe da pesquisa
1.
A systematic approach to evaluate practice-based process- and outcome data applied to the treatment of neovascular age-related macular degeneration.
BMC Ophthalmol
; 20(1): 21, 2020 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31918701
2.
Tracing the natural course of visual acuity and quality of life in neovascular age-related macular degeneration: a systematic review and quality of life study.
BMC Ophthalmol
; 17(1): 120, 2017 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28693519
3.
Distinguishing between Better and Worse Visual Acuity by Studying the Correlation with Quality of Life in Neovascular Age-Related Macular Degeneration.
Ophthalmology
; 123(11): 2408-2412, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27568997
4.
Analysis of rare variants in the CFH gene in patients with the cuticular drusen subtype of age-related macular degeneration.
Mol Vis
; 21: 285-92, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25814826
5.
Vogt-Koyanagi-Harada-Like Disease with Loss of Visual Acuity due to Sunitinib Treatment Restored after Switch in Therapy: A Case Report.
Case Rep Ophthalmol
; 15(1): 184-188, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38456120
6.
Perspectives and Update on the Global Shortage of Verteporfin (Visudyne®).
Ophthalmol Ther
; 13(7): 1821-1831, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38753294
7.
Association of Risk Variants in the CFH Gene With Elevated Levels of Coagulation and Complement Factors in Idiopathic Multifocal Choroiditis.
JAMA Ophthalmol
; 141(8): 737-745, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37410486
8.
Stargardt disease: monitoring incidence and diagnostic trends in the Netherlands using a nationwide disease registry.
Acta Ophthalmol
; 100(4): 395-402, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34431609
9.
A systematic review of the adverse events of intravitreal anti-vascular endothelial growth factor injections.
Retina
; 31(8): 1449-69, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21817960
10.
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion: The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial.
Ophthalmol Retina
; 4(6): 576-587, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107188
11.
Extending the Spectrum of EYS-Associated Retinal Disease to Macular Dystrophy.
Invest Ophthalmol Vis Sci
; 60(6): 2049-2063, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31074760
12.
Effect of growth factors on proliferation and expression of growth factor receptors in a human lens epithelial cell line.
J Cataract Refract Surg
; 32(3): 510-4, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16631066
13.
A prospective, observational, open-label, multicentre study to investigate the daily treatment practice of ranibizumab in patients with neovascular age-related macular degeneration.
Acta Ophthalmol
; 93(2): 126-33, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25488348
14.
Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis.
Clin Infect Dis
; 39(9): e88-94, 2004 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15494900
15.
Achieving balance in the treatment and monitoring of neovascular age-related macular degeneration in the real world: lessons from the Netherlands cohort of the AURA study.
Acta Ophthalmol
; 97(2): e323-e324, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30318723
16.
Effect of extracellular matrix on proliferation and differentiation of porcine lens epithelial cells.
Graefes Arch Clin Exp Ophthalmol
; 243(7): 695-700, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15702326